Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-12-20 4:36 pm Sale |
2023-12-18 | 13G | Structure Therapeutics Inc. GPCR |
BIOTECHNOLOGY VALUE FUND L P | 2,438,964 1.800% |
-10,221,554 (-80.74%) |
Filing History |
| 2023-12-19 4:53 pm Purchase |
2023-12-15 | 13G | AC Immune SA ACIU |
BIOTECHNOLOGY VALUE FUND L P | 14,571,236 14.800% |
7,142,857 (+96.16%) |
Filing History |
| 2023-12-18 4:35 pm Unchanged |
2023-12-13 | 13D | Rain Enhancement Technologies Holdco Inc RAIN |
BIOTECHNOLOGY VALUE FUND L P | 3,526,729 12.800% |
0 (Unchanged) |
Filing History |
| 2023-12-04 4:33 pm Purchase |
2023-11-22 | 13G | SAB Biotherapeutics, Inc. SABS |
BIOTECHNOLOGY VALUE FUND L P | 917,828 9.990% |
917,828 (New Position) |
Filing History |
| 2023-11-20 5:07 pm Purchase |
2023-11-17 | 13D | Molecular Partners AG MOLN |
BIOTECHNOLOGY VALUE FUND L P | 8,696,205 23.900% |
2,203,688 (+33.94%) |
Filing History |
| 2023-11-17 4:52 pm Purchase |
2023-11-15 | 13D | Repare Therapeutics Inc. RPTX |
BIOTECHNOLOGY VALUE FUND L P | 10,333,600 24.500% |
1,235,000 (+13.57%) |
Filing History |
| 2023-11-13 4:45 pm Purchase |
2023-10-31 | 13G | enGene Holdings Inc. Common Stock ENGN |
BIOTECHNOLOGY VALUE FUND L P | 3,196,439 13.200% |
3,196,439 (New Position) |
Filing History |
| 2023-11-07 4:41 pm Purchase |
2023-11-03 | 13G | Molecular Partners AG MOLN |
BIOTECHNOLOGY VALUE FUND L P | 6,492,517 17.900% |
1,982,445 (+43.96%) |
Filing History |
| 2023-11-06 1:47 pm Purchase |
2023-11-02 | 13D | POINT Biopharma Global Inc. PNT |
BIOTECHNOLOGY VALUE FUND L P | 17,437,375 16.500% |
8,259,627 (+90.00%) |
Filing History |
| 2023-11-03 5:20 pm Purchase |
2023-11-02 | 13D | Repare Therapeutics Inc. RPTX |
BIOTECHNOLOGY VALUE FUND L P | 9,098,600 21.600% |
806,612 (+9.73%) |
Filing History |
| 2023-10-16 4:34 pm Purchase |
2023-10-04 | 13G | VistaGen Therapeutics, Inc. VTGN |
BIOTECHNOLOGY VALUE FUND L P | 2,777,245 9.990% |
2,777,245 (New Position) |
Filing History |
| 2023-09-25 4:35 pm Purchase |
2023-08-31 | 13D | Inventiva S.A. IVA |
BIOTECHNOLOGY VALUE FUND L P | 8,545,499 16.500% |
587,361 (+7.38%) |
Filing History |
| 2023-09-18 4:35 pm Purchase |
2023-09-07 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
BIOTECHNOLOGY VALUE FUND L P | 4,370,024 9.400% |
4,370,024 (New Position) |
Filing History |
| 2023-09-14 4:23 pm Purchase |
2023-09-12 | 13D | Olema Pharmaceuticals, Inc. OLMA |
BIOTECHNOLOGY VALUE FUND L P | 9,135,893 16.700% |
1,724,390 (+23.27%) |
Filing History |
| 2023-08-17 4:52 pm Unchanged |
2023-08-10 | 13D | Rain Enhancement Technologies Holdco Inc RAIN |
BIOTECHNOLOGY VALUE FUND L P | 3,526,729 12.800% |
0 (Unchanged) |
Filing History |
| 2023-08-17 4:49 pm Unchanged |
2023-08-10 | 13D | Pieris Pharmaceuticals, Inc. PIRS |
BIOTECHNOLOGY VALUE FUND L P | 257,623 20.800% |
0 (Unchanged) |
Filing History |
| 2023-08-10 4:34 pm Purchase |
2023-07-31 | 13G | Forte Biosciences, Inc. FBRX |
BIOTECHNOLOGY VALUE FUND L P | 119,284 8.200% |
119,284 (New Position) |
Filing History |
| 2023-07-06 5:23 pm Purchase |
2023-06-26 | 13G | Unicycive Therapeutics, Inc. UNCY |
BIOTECHNOLOGY VALUE FUND L P | 3,470,225 9.990% |
3,470,225 (New Position) |
Filing History |
| 2023-06-30 4:41 pm Unchanged |
2023-06-27 | 13D | MoonLake Immunotherapeutics MLTX |
BIOTECHNOLOGY VALUE FUND L P | 21,751,284 35.800% |
0 (Unchanged) |
Filing History |
| 2023-06-30 4:33 pm Purchase |
2023-06-22 | 13G | Revolution Medicines, Inc. RVMD |
BIOTECHNOLOGY VALUE FUND L P | 7,555,588 7.100% |
5,745,039 (+317.31%) |
Filing History |